Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative network analysis revealed the molecular function of folic acid on immunological enhancement in a sheep model. | Front Immunol | 2022 | 36032143 | PubTator, text mining | PubMed |
| Amphiphilic Aminated Derivatives of [60]Fullerene as Potent Inhibitors of Tumor Growth and Metastasis. | Adv Sci (Weinh) | 2022 | 36031401 | PubTator, text mining | PubMed |
| Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | J Biol Chem | 2022 | 36030824 | PubTator, text mining | PubMed |
| MYH9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mTOR axis. | Cell Biol Int | 2022 | 36030536 | PubTator, text mining | PubMed |
| Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation. | Viruses | 2022 | 36016386 | PubTator, text mining | PubMed |
Identification of Transferrin Receptor 1 (TfR1) Overexpressed in Lung Cancer Cells, and Internalization of Magnetic Au-CoFe2O4 Core-Shell Nanoparticles Functionalized with Its Ligand in a Cellular Model of Small Cell Lung Cancer (SCLC). | Pharmaceutics | 2022 | 36015341 | PubTator, text mining | PubMed |
| Depolarizing Effects in Hydrogen Bond Energy in 310-Helices Revealed by Quantum Chemical Analysis. | Int J Mol Sci | 2022 | 36012292 | PubTator, text mining | PubMed |
| Protein Profiling of a Cellular Model of NAFLD by Advanced Bioanalytical Approaches. | Int J Mol Sci | 2022 | 36012291 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. | Cancers (Basel) | 2022 | 36010842 | PubTator, text mining | PubMed |
| Pathological and Molecular Features of Nodal Peripheral T-Cell Lymphomas. | Diagnostics (Basel) | 2022 | 36010351 | PubTator, text mining | PubMed |
| CK2 and the Hallmarks of Cancer. | Biomedicines | 2022 | 36009534 | PubTator, text mining | PubMed |
| Comprehensive Etiologic Analyses in Pediatric Cochlear Implantees and the Clinical Implications. | Biomedicines | 2022 | 36009393 | PubTator, text mining | PubMed |
| Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research. | Front Pharmacol | 2022 | 36003509 | PubTator, text mining | PubMed |
| Uncovering the functions of plasma proteins in ulcerative colitis and identifying biomarkers for BPA-induced severe ulcerative colitis: A plasma proteome analysis. | Ecotoxicol Environ Saf | 2022 | 35999755 | PubTator, text mining | PubMed |
| Mechanisms and prospects of circular RNAs and their interacting signaling pathways in colorectal cancer. | Front Oncol | 2022 | 35992800 | PubTator, text mining | PubMed |
| Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases. | Mol Ther Nucleic Acids | 2022 | 35991314 | PubTator, text mining | PubMed |
| Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine. | EPMA J | 2022 | 35990779 | PubTator, text mining | PubMed |
| Heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies with evidence for primary cilia-dependent defects in Hedgehog signaling. | Genet Med | 2022 | 35980381 | PubTator, text mining | PubMed |
| DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. | Signal Transduct Target Ther | 2022 | 35973989 | PubTator, text mining | PubMed |
| Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1. | J Biol Chem | 2022 | 35973513 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=45